Xp11.2 translocation renal cell carcinomas in young adults

[1]  M. Stöckle,et al.  Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size , 2014, Virchows Archiv.

[2]  Rong Yang,et al.  Laparoscopic radiofrequency ablation-assisted enucleation of Xp11.2 translocation renal cell carcinoma: A case report , 2014, Oncology letters.

[3]  M. Ladanyi,et al.  Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage , 2014, Modern Pathology.

[4]  Hong-cheng Song,et al.  Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions. , 2014, Journal of pediatric surgery.

[5]  M. Ladanyi,et al.  Utilization of a TFE3 Break-apart FISH Assay in a Renal Tumor Consultation Service , 2013, The American journal of surgical pathology.

[6]  D. Grignon,et al.  TFE3 Break-apart FISH Has a Higher Sensitivity for Xp11.2 Translocation–associated Renal Cell Carcinoma Compared With TFE3 or Cathepsin K Immunohistochemical Staining Alone: Expanding the Morphologic Spectrum , 2013, The American journal of surgical pathology.

[7]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[8]  D. Pasquier,et al.  Le carcinome rénal à translocation Xp11.2 de l’adulte de plus de 50 ans : à propos de quatre cas , 2012 .

[9]  T. Klatte,et al.  Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis. , 2012, American journal of clinical pathology.

[10]  W. Linehan,et al.  Translocation Renal Cell Carcinomas in Adults: A Single-institution Experience , 2012, The American journal of surgical pathology.

[11]  J. Cheville,et al.  TFE3 Rearrangements in Adult Renal Cell Carcinoma: Clinical and Pathologic Features With Outcome in a Large Series of Consecutively Treated Patients , 2012, The American journal of surgical pathology.

[12]  C. Pan,et al.  Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. , 2012, Histology and histopathology.

[13]  M. Rubin,et al.  Validation of a TFE3 Break-apart FISH Assay for Xp11.2 Translocation Renal Cell Carcinomas , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[14]  K. Moon,et al.  Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma , 2011, Virchows Archiv.

[15]  K. Kihara,et al.  Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. , 2011, Urology.

[16]  Xiao-jun Zhou,et al.  Xp11.2 Translocation Renal Cell Carcinomas Have a Poorer Prognosis Than Non-Xp11.2 Translocation Carcinomas in Children and Young Adults: A Meta-analysis , 2010, International journal of surgical pathology.

[17]  P. Tamboli,et al.  Vascular endothelial growth factor‐targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma , 2010, Cancer.

[18]  Choung-Soo Kim,et al.  Age at diagnosis is an independent predictor of small renal cell carcinoma recurrence-free survival. , 2009, The Journal of urology.

[19]  L. Truong,et al.  Clinicopathologic features of renal cell carcinoma in young adults: a comparison study with renal cell carcinoma in older patients. , 2009, International Journal of Clinical and Experimental Pathology.

[20]  Y. Ishikawa,et al.  Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry , 2009, Clinical Cancer Research.

[21]  P. Argani,et al.  Translocation renal cell carcinoma , 2008, Cancer.

[22]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.

[23]  F. Guillé,et al.  Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. , 2007, European urology.

[24]  W. Rathmell,et al.  Renal cell carcinoma , 2007, Current opinion in oncology.

[25]  A. Pappo,et al.  Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. , 2006, American journal of clinical pathology.

[26]  M. Ladanyi,et al.  Translocation carcinomas of the kidney. , 2005, Clinics in laboratory medicine.

[27]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[28]  M. Ladanyi,et al.  PRCC-TFE3 Renal Carcinomas: Morphologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of an Entity Associated With the t(X;1)(p11.2;q21) , 2002, The American journal of surgical pathology.

[29]  M. Ladanyi,et al.  Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. , 2001, The American journal of pathology.

[30]  B. Delahunt,et al.  Classification of renal cell carcinoma , 1997, Cancer.

[31]  W. Liang,et al.  Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study. , 2014, International journal of clinical and experimental pathology.

[32]  M. Picken,et al.  Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. , 2007, American journal of clinical pathology.